1-4 of 4
Shannon Grande, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Molecular and Phenotypic Profiling of Drug Product and Post-Infusion Samples from CRB-402, an Ongoing: Phase I Clinical Study of bb21217 a BCMA-Directed CAR T Cell Therapy

Olivia C Finney, Ashish Yeri, PhD, Pingping Mao, PhD, Chetanya Pandya, PhD, Eric Alonzo, PhD, Gregory Hopkins, BS, Sebastian Hymson, BS, Tiffany Hu, BS, Marianna Foos, MS, Sneha Bhadoriya, MS, Stephanie Hintzen, BS, Maple Gioia, MS, Alison Timm, MS, Monica Massaro, MPH, Ron Hause, PhD, Shari Kaiser, PhD, Nathan Martin, PhD, Melissa Alsina, MD, Nina Shah, MD, Noopur S. Raje, MD, Jesus G. Berdeja, MD, Shannon Grande, PhD, Hans Bitter, PhD, Fabio Petrocca, MD, Kevin M. Friedman, PhD, Dipen Sangurdekar, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 3–4.
https://doi.org/10.1182/blood-2020-142426
Published: 2020
Journal Articles

Knockout of CBLB Greatly Enhances Anti-Tumor Activity of CAR T Cells

Kathryn Hooper, PhD, Kyle Havens, PhD, Anne-Rachel Krostag, BS, Michael S Magee, PhD, Unja Martin, Ankit Gupta, PhD, Yegor Smurnyy, PhD, Lisa Pechilis, Amanda Rode, Andrew Chavkin, MS, Shannon Grande, PhD, Richard A. Morgan, PhD, Jordan Jarjour, PhD, Alexander Astrakhan, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 338.
https://doi.org/10.1182/blood-2018-99-119247
Published: 2018
Journal Articles

ROR1-Directed Chimeric Antigen Receptor T Cell Recognition of Self-Antigen Is Associated with Acute Toxicity, T Cell Dysfunction, and Poor Tumor Control.

James B Rottman, DVM, PhD DACVP, Kenneth Ganley, BS, Brenna Daly, BS, Holly M. Horton, PhD, Kevin M. Friedman, Molly Perkins, PhD, Shannon Grande, PhD, Claire J Rhodes, BS, Richard A. Morgan, PhD, Christopher J. Horvath, DVM, MS, DACVP
Journal: Blood
Blood (2017) 130 (Supplement 1): 4450.
https://doi.org/10.1182/blood.V130.Suppl_1.4450.4450
Published: 2017
Journal Articles

Manufacturing an Enhanced CAR T Cell Product By Inhibition of the PI3K/Akt Pathway During T Cell Expansion Results in Improved In Vivo Efficacy of Anti-BCMA CAR T Cells

Molly R. Perkins, D.Phil., Shannon Grande, PhD, Amanda Hamel, BS, Holly M. Horton, PhD, Tracy E. Garrett, BA, Sara M. Miller, Howard J. Latimer, IV, BS, Christopher J. Horvath, DVM, MS, DACVP, Michael Kuczewski, MS, Kevin M. Friedman, PhD, Richard A. Morgan, PhD
Journal: Blood
Blood (2015) 126 (23): 1893.
https://doi.org/10.1182/blood.V126.23.1893.1893
Published: 2015